ALFA Finder
India's fastest NSE & BSE filing alerts on Telegram, filtered to the stocks you hold
Telegram alerts
alfafinder.com →
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
44 announcements
Q2 FY27: standalone income up 32% YoY to ₹305.4 Cr on bromine pricing; consolidated PAT only up 8%. H1 consolidated EBITDA down 5.2%; SOP guidance cut to 3.5–4k t, with fuel and PVC risks.
Q2FY27 consolidated income Rs301.6 Cr (+25.9% YoY), PAT Rs31.3 Cr (+7.9%). Bromine revenue +76%, bromine derivatives +81%. Strategy centres on SiC semiconductor fab and zinc-bromide batteries.
Archean Chemical allotted 6,143 equity shares to one grantee under its ESOP 2022 on 29-Oct-2026. Paid-up capital rose to 12,34,64,537 shares.
Archean Chemical Industries Ltd reported revenue from operations of ₹297.4 Cr (+27.5% YoY) and net profit of ₹31.3 Cr (+7.9% YoY) for Q2 FY27.
Archean Chemical Industries Limited informed that CRISIL downgraded its ratings for ₹1,531 Crore in long-term bank facilities from CRISIL A/Negative to CRISIL A-/Stable.
Archean Chemical Industries Limited scheduled a board meeting on October 29, 2026, to consider and approve the financial results for the quarter ended September 30, 2026.
The company filed its quarterly Shareholding Pattern under Regulation 31, detailing the promoter and public equity distribution as of September 30, 2026.
Promoter entity Chemikas Speciality LLP created pledges on 10,87,500 Archean shares on 17 Sept 2026. The shares were encumbered as collateral for loans from Piramal Finance and JM Financial.
Promoter Chemikas Speciality LLP pledged 10,87,500 shares of Archean Chemical Industries as loan collateral on 17 Sept 2026. Total encumbered holding rose to 30.53% of the company.
Chemikas Speciality LLP created a pledge on 30,000 shares of Archean Chemical Industries Limited as collateral for loans.
SBI Mutual Fund sold 1,47,599 shares of Archean Chemical Industries Ltd, representing 0.1196% of the company's equity, via market sale on September 03, 2026.
Archean Chemical reported Q1 FY27 consolidated revenue of INR 3,328.1M, up 10.7% YoY. Standalone margins improved to 25.3%, with bromine derivatives business turning EBITDA positive for the first time.
Archean reported Q1FY27 consolidated revenue of ₹3,328 Mn, up 11% YoY. Strategy focuses on bromine derivatives, semiconductors via SiCSem, and energy storage through Offgrid Energy Labs.
Archean Chemical Industries Ltd reported revenue from operations of ₹327.2 Cr (+11.9% YoY) and net profit of ₹30.4 Cr (-24.2% YoY) for Q1 FY27.
Chemikas Speciality LLP released the pledge on 5,200 shares of Archean Chemical Industries Ltd. The release occurred after repaying the loan availed.
Archean Chemical Industries submitted its Reconciliation of Share Capital Audit Report for the quarter ended June 30, 2026, as required by SEBI regulations.
Archean Chemical Industries has scheduled a board meeting for July 30, 2026, to approve the company's un-audited financial results for the quarter ended June 30, 2026.
Archean Chemical Industries clarified that recent trading volume spikes are purely market-driven. The company confirmed no undisclosed price-sensitive information exists.
Archean Chemical's investee, Offgrid Energy Labs, inaugurated a 10 MWh Zinc Bromide battery pilot facility in the UK. This marks a transition toward commercial-scale production synergy.
Chemikas Speciality LLP pledged 8.5 lakh shares as loan collateral on 30 June 2026 and released 22 lakh shares on 3 July 2026. The disclosures are filed under SEBI Regulation 31.
Archean Chemical Industries received a Rs. 0.34 Crore income tax penalty for AY 2017-18. The company intends to appeal the order before the Commissioner of Income Tax.
Archean Chemical received an income tax penalty order of ₹0.34 Crore. The company intends to file an appeal against this order.
CTL Trusteeship Ltd received a pledge of 79,00,000 shares (6.40%) in Archean Chemical Industries Ltd as security trustee for lenders. This is a non-promoter encumbrance, not a sale or acquisition of ownership.
Archean Chemical Industries held its 17th AGM on June 12, 2026. Shareholders approved re-appointment of auditors and independent directors.
The 17th AGM of Archean Chemical Industries was held on June 12, 2026, with all resolutions passed. Shareholders approved a final dividend of Rs.2.50 per share and reappointed directors.
Chemikas Speciality LLP released pledges on 59,29,990 shares of Archean Chemical Industries after repaying loans. This reduces promoter encumbrance from 17.20% to 12.41%, improving the company's pledge profile.
Archean Chemical Industries will invest ₹170 Crore in its wholly-owned subsidiary, Acume Chemicals. The investment supports capital base strengthening and future business expansion.
Archean Chemical Industries submitted its FY2026 Annual Secretarial Compliance Report. The company disclosed a Rs. 0.0035 Crore penalty paid for delayed Compliance Officer appointment.
Promoter entity Chemikas Speciality LLP pledged 9,50,000 shares of Archean Chemical Industries as loan collateral. This increases promoter-level encumbrance and total pledged equity.
Archean Chemical Industries scheduled its AGM for June 12, 2026, to approve financial statements and dividends. Shareholders will also consider director re-appointments and auditor remunerations.